Surgical Outcomes in AFT-46: CHIO3: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
Google Scholar   
Citation:
Meeting Instance:
AATS 2025
Year:
2025
Type:
Abstract
Sub type:
Funding:
AFT
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
AstraZeneca  
Grants:
 
Corr. Author:
 
Authors:
                         
Networks:
BAPTIST, CA249, LAPS-IL036, LAPS-MA036, LAPS-NC010, NY141, VA009   
Study
AFT-46
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: